Literature DB >> 23396035

Hummingbird sign in progressive supranuclear palsy.

Rajesh Verma1, Mani Gupta.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23396035      PMCID: PMC6081112          DOI: 10.5144/0256-4947.2012.663

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


× No keyword cloud information.
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) is a neurological disorder characterized by degeneration of the midbrain, basal ganglia and other structures like the frontal lobe, pyramidal tracts and cerebellum. It manifests in middle and late adult age by progressive supranuclear gaze, palsy, postural instability with recurrent falls, mainly in a backwards direction, symmetrical rigidity. frontal lobe features, and dementia.1 It can be confused with other diseases like idiopathic Parkinson disease, multiple-system atrophy and corticobasal degeneration. To date, the diagnosis of progressive supranuclear palsy is based on clinical grounds. No biomarker has been discovered. The neuroimaging characteristics, particularly the hummingbird sign, is considered quite suggestive of progressive supranuclear palsy.

CASE

A 58-year-old male presented with insidious-onset, progressive difficulty in initiation of, and slowness in execution of movements for the last 5 years. The patient had recurrent falls starting 6 months from onset of symptoms. For the same duration, he had impaired gait and a change in speech. The gait was short shuffling gait with hesitation in initiation and difficulty in walking through narrow passages along with freezing episodes. Speech gradually became slow, low in volume and monotonous in character. Family members noticed impaired cognition. He showed a poor response to a trial of levodopa therapy. There was no history of trauma, stroke-like episodes, hallucinations, fluctuations of clinical symptoms or dysautonomia. His BP was 169/86 mm Hg with no evidence of postural hypotension. He had a staring look with infrequent blinking and presence of neck dystonia. A mini–mental status examination score was 21/30. He had vertical gaze palsy, hypermetric horizontal saccades and hypometric vertical saccades, impaired optokinetic nystagmus and positive square-wave jerks. There was rigidity in both the upper and lower limbs, and the plantars were bilaterally extensor. Other parameters of neurological examination were essentially normal. The liver function test did not reveal any abnormality. Hemoglobin was 130 g/L, total leukocyte count was 6500 cells/cu. mm, random blood sugar was 126 mg/dL, and serum creatinine was 1.2 mg/dL. Magnetic resonance imaging T2-weighted image showed atrophy of the midbrain tegmentum with relative preservation of the shape of the pons (Figures 1, 2). These images resemble the shape of a hummingbird, and are thus known as the “hummingbird sign.”
Figure 1

Mid sagittal MRI T2-weighted image revealing midbrain atrophy (thin arrow), and cistern dilatation with preserved pons (thick arrow) resembling a hummingbird.

Figure 2

Mid sagittal MRI T2 weighted image of age sex matched control revealing absence of hummingbird sign

DISCUSSION

Progressive supranuclear palsy is a neurodegenerative disorder, mainly affecting eye movements, cognition and posture.2 Close differential diagnoses of this condition are Parkinson disease, multiple-system atrophy, and corticobasal degeneration.3 MRI findings of progressive supranuclear palsy are midbrain atrophy with dilated cisterns, thinning of the quadrigeminal plate, third ventricular dilatation and the characteristic hummingbird sign.4 Using mid-sagittal plain MRI, the hummingbird sign was demonstrated in all progressive supranuclear palsy patients but was negative in Parkinson disease and controls. hummingbird sign in progressive supranuclear palsy patients was due to atrophy of the midbrain and relative lengthening of the interpeduncular fossa and preserved pons.5 Hummingbird sign on MRI has a sensitivity of around 100%. hummingbird sign on MRI can be a useful diagnostic clue for physicians for confirmation of diagnosis of progressive supranuclear palsy and can help to differentiate from Parkinson disease, which is a treatable neurological disorder.
  5 in total

1.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.

Authors:  F Yekhlef; G Ballan; F Macia; O Delmer; C Sourgen; F Tison
Journal:  J Neural Transm (Vienna)       Date:  2003-02       Impact factor: 3.575

2.  Progressive Supranuclear Palsy.

Authors:  Lawrence I. Golbe
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

Review 3.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.

Authors:  David R Williams; Andrew J Lees
Journal:  Lancet Neurol       Date:  2009-03       Impact factor: 44.182

4.  Study of the rostral midbrain atrophy in progressive supranuclear palsy.

Authors:  Naoko Kato; Kimihito Arai; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

5.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Authors:  Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Journal:  Arch Neurol       Date:  2009-06
  5 in total
  1 in total

Review 1.  Visual Illusions in Radiology: Untrue Perceptions in Medical Images and Their Implications for Diagnostic Accuracy.

Authors:  Robert G Alexander; Fahd Yazdanie; Stephen Waite; Zeshan A Chaudhry; Srinivas Kolla; Stephen L Macknik; Susana Martinez-Conde
Journal:  Front Neurosci       Date:  2021-06-11       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.